Provided by Tiger Trade Technology Pte. Ltd.

Capstone Therapeutics Corp

0.1885
-0.0005-0.26%
Volume:114.36K
Turnover:21.44K
Market Cap:3.88M
PE:-0.08
High:0.1912
Open:0.1829
Low:0.1812
Close:0.1890
52wk High:2.07
52wk Low:0.1801
Shares:20.58M
Float Shares:11.97M
Volume Ratio:0.51
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4235
EPS(LYR):-4.1220
ROE:-114.21%
ROA:-3.47%
PB:0.31
PE(LYR):-0.05

Loading ...

Company Profile

Company Name:
Capstone Therapeutics Corp
Exchange:
NASDAQ
Establishment Date:
1987
Employees:
93
Office Location:
5141 West 122nd Street,Alsip,Illinois,United States
Zip Code:
60803
Fax:
- -
Introduction:
Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone veneer sidings, hardscapes and related moisture management products, lath products, and fireplaces offered under the Instone and Northeast Masonry names for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. operates as a subsidiary of BP Peptides, LLC

Directors

Name
Position
Matthew E. Lipman
Chief Executive Officer and Director
Michael M. Toporek, III
Chairman and Director
Charles Dana
Lead Independent Director
Elwood D. Howse, Jr.
Independent Director
Fredric J. Feldman
Independent Director
John M. Holliman, III
Independent Director
Gordon Strout
Director

Shareholders

Name
Position
Kevin Grotke
Chief Executive Officer of TotalStone, LLC and President
Matthew E. Lipman
Chief Executive Officer and Director
Edward Schultz
Chief Financial Officer